Roche Holding AG Logo

Roche Holding AG (RHHVF)

OTC

Currency in USD
468.60
+10.09 (+2.20%)

Closed

Aug 21, 2026

Day's Range

451.30
474.23

52 wk Range

314.15
490.33

Overview - RHHVF - Roche Holding AG

Key Statistics

Valuation

Enterprise Value

500.48B

P/E (Trailing)

‪24.39‬

P/E (Forward)

‪17.60‬

PEG Ratio

‪17.60‬

Price / Sales (TTM)

‪5.93‬

Price / Book

‪9.25‬

EV / EBITDA

‪16.73‬

Profitability

Profit Margin

‪19.60%‬

Operating Margin

‪36.20%‬

Return on Assets

‪13.50%‬

Return on Equity

‪38.10%‬

Ownership

Shares Outstanding

796.76M

Float

654.08M

Held by Insiders

‪0.00%‬

Held by Institutions

‪44.00%‬

Price stats

Beta

‪0.34‬

50-Day Avg

‪426.29‬

200-Day Avg

‪416.34‬

Dividends

Payout Ratio

‪63.93%‬

Frequency

Annual

Analyst Consensus

Buy

1 analysts

Shariah Compliance

Shariah Compliant

Report Date: Feb 20, 2025

Screened by Zoya using the AAOIFI methodology.

Market Cap - RHHVF - Roche Holding AG

Peers - RHHVF - Roche Holding AG

Peer Comparison

Compared with companies in Drug Manufacturers - General listed on OTC.

Profile Summary - RHHVF - Roche Holding AG

About

Roche Holding AG is a Swiss biopharmaceutical and diagnostics company headquartered in Basel, Switzerland. The company develops, manufactures, and markets innovative medicines and diagnostic solutions worldwide, with a strong focus on oncology therapies derived from its integration with Genentech. Its bestselling…

SectorHealthcare
IndustryDrug Manufacturers - General
Employees103.24K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.